FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2111562616> ?p ?o ?g. }

• W2111562616 endingPage "74" @default.
• W2111562616 startingPage "3869" @default.
• W2111562616 abstract "We administered cis-diamminedichloroplatinum(II), 30 mg/m2/day for 5 days by continuous infusion to six patients with head and neck cancer, and compared the total and filterable plasma concentrations of platinum, and toxic effects, with those observed in five additional patients who received the same dose and schedule of cis-diamminedichloroplatinum(II) by intermittent bolus. In the continuous infusion group, the total 5-day exposure to filterable platinum, determined from the area under the concentration-time curve, was 1.5 to 2-fold higher (P less than 0.01) than that observed in the intermittent bolus group although the maximum filterable platinum concentration achieved was 8-fold lower (P less than 0.01). These differences were not reflected by total platinum levels. Subclinical nephrotoxicity, as judged by monitoring the urinary excretion of the renal enzymes N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase, as well as ototoxicity, and the incidence and severity of nausea and vomiting were similar in both groups. In contrast, myelosuppression, and hypomagnesemia were more frequent in the continuous-infusion patients, suggesting that the total exposure to free platinum contributes more to these toxicities than peak levels achieved. Considering the clinically acceptable toxicity observed after administration by continuous infusion, we recommend larger therapeutic trials to define the efficacy of increased tumor exposure to filterable platinum." @default.
• W2111562616 created "2016-06-24" @default.
• W2111562616 creator A5001884360 @default.
• W2111562616 creator A5025438594 @default.
• W2111562616 creator A5034392417 @default.
• W2111562616 creator A5042638245 @default.
• W2111562616 creator A5049980695 @default.
• W2111562616 creator A5090322942 @default.
• W2111562616 date "1988-07-01" @default.
• W2111562616 modified "2023-09-26" @default.
• W2111562616 title "Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients." @default.
• W2111562616 cites W1582307411 @default.
• W2111562616 cites W1660925761 @default.
• W2111562616 cites W1783943263 @default.
• W2111562616 cites W1977443712 @default.
• W2111562616 cites W1979295668 @default.
• W2111562616 cites W198931631 @default.
• W2111562616 cites W1989646995 @default.
• W2111562616 cites W1991463182 @default.
• W2111562616 cites W2013275926 @default.
• W2111562616 cites W2023496931 @default.
• W2111562616 cites W2032528970 @default.
• W2111562616 cites W2038249986 @default.
• W2111562616 cites W2042440620 @default.
• W2111562616 cites W2045155105 @default.
• W2111562616 cites W2050813202 @default.
• W2111562616 cites W2055154319 @default.
• W2111562616 cites W2062225160 @default.
• W2111562616 cites W2095134667 @default.
• W2111562616 cites W2154498516 @default.
• W2111562616 cites W2179956917 @default.
• W2111562616 cites W2225030483 @default.
• W2111562616 cites W2266115160 @default.
• W2111562616 cites W2402537047 @default.
• W2111562616 cites W2412352391 @default.
• W2111562616 cites W2417354031 @default.
• W2111562616 cites W32658358 @default.
• W2111562616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3378222" @default.
• W2111562616 hasPublicationYear "1988" @default.
• W2111562616 type Work @default.
• W2111562616 sameAs 2111562616 @default.
• W2111562616 citedByCount "48" @default.
• W2111562616 countsByYear W21115626162013 @default.
• W2111562616 countsByYear W21115626162016 @default.
• W2111562616 countsByYear W21115626162017 @default.
• W2111562616 countsByYear W21115626162019 @default.
• W2111562616 countsByYear W21115626162020 @default.
• W2111562616 crossrefType "journal-article" @default.
• W2111562616 hasAuthorship W2111562616A5001884360 @default.
• W2111562616 hasAuthorship W2111562616A5025438594 @default.
• W2111562616 hasAuthorship W2111562616A5034392417 @default.
• W2111562616 hasAuthorship W2111562616A5042638245 @default.
• W2111562616 hasAuthorship W2111562616A5049980695 @default.
• W2111562616 hasAuthorship W2111562616A5090322942 @default.
• W2111562616 hasConcept C112705442 @default.
• W2111562616 hasConcept C113280763 @default.
• W2111562616 hasConcept C121608353 @default.
• W2111562616 hasConcept C126189478 @default.
• W2111562616 hasConcept C126322002 @default.
• W2111562616 hasConcept C126894567 @default.
• W2111562616 hasConcept C2776530083 @default.
• W2111562616 hasConcept C2778496288 @default.
• W2111562616 hasConcept C2780580376 @default.
• W2111562616 hasConcept C2780852908 @default.
• W2111562616 hasConcept C29730261 @default.
• W2111562616 hasConcept C42219234 @default.
• W2111562616 hasConcept C43376680 @default.
• W2111562616 hasConcept C71924100 @default.
• W2111562616 hasConcept C90924648 @default.
• W2111562616 hasConcept C98274493 @default.
• W2111562616 hasConceptScore W2111562616C112705442 @default.
• W2111562616 hasConceptScore W2111562616C113280763 @default.
• W2111562616 hasConceptScore W2111562616C121608353 @default.
• W2111562616 hasConceptScore W2111562616C126189478 @default.
• W2111562616 hasConceptScore W2111562616C126322002 @default.
• W2111562616 hasConceptScore W2111562616C126894567 @default.
• W2111562616 hasConceptScore W2111562616C2776530083 @default.
• W2111562616 hasConceptScore W2111562616C2778496288 @default.
• W2111562616 hasConceptScore W2111562616C2780580376 @default.
• W2111562616 hasConceptScore W2111562616C2780852908 @default.
• W2111562616 hasConceptScore W2111562616C29730261 @default.
• W2111562616 hasConceptScore W2111562616C42219234 @default.
• W2111562616 hasConceptScore W2111562616C43376680 @default.
• W2111562616 hasConceptScore W2111562616C71924100 @default.
• W2111562616 hasConceptScore W2111562616C90924648 @default.
• W2111562616 hasConceptScore W2111562616C98274493 @default.
• W2111562616 hasIssue "13" @default.
• W2111562616 hasLocation W21115626161 @default.
• W2111562616 hasOpenAccess W2111562616 @default.
• W2111562616 hasPrimaryLocation W21115626161 @default.
• W2111562616 hasRelatedWork W1980701009 @default.
• W2111562616 hasRelatedWork W2030031931 @default.
• W2111562616 hasRelatedWork W2035517983 @default.
• W2111562616 hasRelatedWork W2074629895 @default.
• W2111562616 hasRelatedWork W2088425824 @default.
• W2111562616 hasRelatedWork W2229196813 @default.
• W2111562616 hasRelatedWork W2374367026 @default.
• W2111562616 hasRelatedWork W2407057785 @default.

• next